返回 
加入收藏
基于利益相关者理论的基本药物可及性影响因素研究
x
请在关注微信后，向客服人员索取文件
| 篇名： | 基于利益相关者理论的基本药物可及性影响因素研究 |
| TITLE： | |
| 摘要： | 目的：为提高基本药物可及性提供建议与对策。方法：在理论分析的基础上设计问卷，向高校、企业、政府机构以及非政府组织等机构的专家调查基本药物可及性各影响因素的重要性，并用层次分析法对回收的有效问卷进行分析与讨论。结果：共发放问卷35份，回收有效问卷27份，有效回收率为77.14％。调查结果显示，医师、药师对国家基本药物制度及基本药物的认知情况，基本药物中标价格的合理程度和基本药物招标过程的公开、公平和公正性是影响基本药物可及性的重要因素；医师对基本药物的处方情况，基本药物配备、报销情况与对基本药物实施“零差率”销售的公立基层医疗卫生机构财政补偿的到位情况是次要影响因素；基层医疗卫生机构对基本药物使用的监测情况（如处方率等）、社保部门参与基本药物集中招标采购的情况、基本药物定价的合理程度和基本药物的价格监测情况与对基本药物生产企业的补偿情况是一般影响因素。结论：基本药物可及性涉及众多利益相关者，各主体从不同层面对其产生影响，因此需协调各利益相关主体，以逐步实现提高基本药物可及性的目标。 |
| ABSTRACT： | OBJECTIVE： To provide suggestions and countermeasures for improving the accessibility of national essential medicines. METHODS： Based on the theoretical analysis， the questionnaire was designed for the pre-survey and formal survey on the experts from universities， enterprises， government agencies and non-governmental organizations， and analytic hierarchy process was used to analyze and discuss the valid questionnaire. RESULTS： Totally 35 question naires were sent out and 27 were effectively received with effective rate of 77.14％. The physicians and pharmacists’ cognition of essential medicine system and essential medicine， and the reasonable degree of public bid prices of essential medicine， the fairness and impartiality of essential medicine bidding process were the key influential factors； the prescription， provision， reimbursement of essential medicine， and the financial compensation to primary public health care institutions that sell essential medicine by zero-slip were the secondary factors； primary health care institutions’ monitoring on the use of essential medicine （such as prescription rate， etc.）， the participation of social security sector in bidding and purchasing of essential medicine， the reasonable degree of pricing of essential medicine， the monitoring of the price of essential medicine， and the compensation to manufacturers of essential medicine were the general factors. CONCLUSIONS： The accessibility of essential medicine involves many stakeholders， whom impact from different levels. Therefore， all relevant stakeholders should be coordinated to gradually improve the accessibility of essential medicines. |
| 期刊： | 2016年第27卷第30期 |
| 作者： | 李军，褚淑贞 |
| AUTHORS： | LI Jun，CHU Shuzhen |
| 关键字： | 利益相关者；基本药物；可及性；调查 |
| KEYWORDS： | Stakeholders； Essential medicine； Accessibility； Investigation |
| 阅读数： | 344 次 |
| 本月下载数： | 8 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
